Valuation: Pulsenmore Ltd.

Market Cap 96.46M 31.91M 27.99M 25.92M 23.85M 45.11M 3.05B 45.99M 309M 121M 1.5B 120M 117M 5.18B P/E 2024
-6.97x
P/E 2025 -8.49x
Enterprise Value 28.89M 9.56M 8.38M 7.76M 7.14M 13.51M 915M 13.77M 92.53M 36.29M 449M 35.89M 35.1M 1.55B EV / Sales 2024
15,496,698x
EV / Sales 2025 1,705,119x
Free-Float
56.6%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer 63 2014-12-27
Director of Finance/CFO - -
Chief Operating Officer - 2022-07-31
Director TitleAgeSince
Director/Board Member 63 2014-12-27
Chairman 79 2020-08-23
Director/Board Member 73 2020-11-30
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00% - - 32.08M
+1.35%-6.70%-15.35%+18.92% 3.82B
-1.39%-7.64%+66.88% - 1.52B
+1.35%+0.56%+21.49% - 742M
+3.54%0.00%-1.50%-16.64% 147M
-9.61%-14.51%+62.76%+66.85% 127M
-9.01%-11.14%+5.36%+4.59% 72.86M
Average -1.97%-2.31%+23.27%+18.43% 1.07B
Weighted average by Cap. +0.42%-5.88%+10.42%+18.87%

Financials

2024 2025
Net sales 9.66 3.2 2.8 2.6 2.39 4.52 305.87 4.61 30.94 12.14 150.21 12 11.74 518.74 40.02 13.24 11.61 10.76 9.9 18.72 1.27K 19.08 128.19 50.28 622.28 49.72 48.63 2.15K
Net income -36.74M -12.15M -10.66M -9.87M -9.08M -17.18M -1.16B -17.51M -118M -46.15M -571M -45.63M -44.63M -1.97B -15.85M -5.24M -4.6M -4.26M -3.92M -7.41M -502M -7.56M -50.77M -19.91M -246M -19.69M -19.26M -851M
Net Debt -102M -33.71M -29.57M -27.38M -25.2M -47.66M -3.23B -48.58M -326M -128M -1.58B -127M -124M -5.47B -67.57M -22.35M -19.6M -18.16M -16.71M -31.6M -2.14B -32.21M -216M -84.88M -1.05B -83.93M -82.1M -3.63B
Logo Pulsenmore Ltd.
Pulsenmore Ltd is an Israel-based medical equipment company. The Company engaged in the field of research and development activity, production, marketing and sales worldwide of solutions and technologies that concern portable ultrasound devices for home use by the patient for a remote physical examination or monitoring using telehealth technology. he company has developed and sells two miniaturized ultrasound systems: the first is called PulseNmore ES, for performing home ultrasound tests for pregnant women; and the second is called PulseNmore FC, for performing a self-test of the size of the follicles in women who are in the process in vitro fertilization. Both systems make use of a smart mobile phone and make the test accessible without the need o visit in clinic or hospital, while being able to transfer film for the doctor, the treating medical team or the hotline online. Moreover the COmpany delivers software for its products.
Employees
-